Neogen Chemicals (NEOGEN) Q1 25/26 earnings summary

Executive summary

• Q1 FY26 demonstrated resilience and volume-driven growth despite the Dahej plant fire, with initial commercial sales from Neogen Ionics and ongoing recovery efforts, including insurance claims and plant rebuilding.

• Leadership transition announced: Mr. Haridas Kanani to retire as Chairman and MD in September 2025, becoming Chairman Emeritus, with Mr. Anurag Surana designated as Chairman.

• Board approved unaudited standalone and consolidated financial results for Q1 FY26 and related FY 2024-25 reports.

• 36th AGM scheduled for September 26, 2025, with record date for dividend eligibility set for September 19, 2025.

• Appointment and re-appointment of key directors and reconstitution of board committees effective October 1, 2025.

Financial highlights

• Q1 FY26 consolidated revenue reached INR 186.7 crore, up 4% year-over-year; standalone revenue at INR 184.6 crore.

• Organic revenue grew to INR 165 crore; inorganic revenue at INR 22 crore.

• EBITDA stood at INR 31.5 crore, up 2% year-over-year, with consolidated EBITDA margin at 16.9%.

• Consolidated PAT was INR 10.3 crore, down 11% year-over-year; standalone PAT at INR 14.23 crore.

• Earnings per share (consolidated) at INR 3.89; standalone EPS at INR 5.40.

Outlook and guidance

• Near-term revenue guidance revised to reflect operational challenges, but long-term growth trajectory remains robust.

• Base business revenue guidance maintained at INR 825-875 crore for FY26.

• Battery chemicals segment and JV with Morita expected to drive future growth, with new capacities targeting global demand.

• CapEx for battery chemicals and salt expansion on track, with major expenditures expected in coming quarters.

• Seasonal factors expected to result in stronger H2 performance.